Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil
New offering restores lipid layer and brings hydration to all three layers of tear film damaged by Dry Eye.
Allergan has launched the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when Meibomian Gland Dysfunction (MGD) patients suffer from Dry Eye. MEGA-3 is formulated with flaxseed and castor oil, two natural, plant-based oils which protect tears from evaporating while nourishing the lipid layer damaged by Dry Eye and providing essential hydration to all three layers of the tear film. It's clinically proven to treat the signs and symptoms of Dry Eye.
"I recommend MEGA-3 for patients suffering from Dry Eye symptoms associated with MGD, who are looking for relief. In addition, MEGA-3 is specially formulated for stability, so no shaking is required -- just drop and go." said Milton M. Hom, OD, FAAO.
An estimated 25 million people in the US suffer from Dry Eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing. MEGA-3 also contains carboxymethylcellulose (CMC), an active lubricant found in all REFRESH OPTIVE formulas. This water-loving polymer, binds to epithelial cells to maintain moisture on the ocular surface for rapid on-eye comfort and long-lasting relief."As the innovators of the number one doctor-recommended brand of artificial tears1, we are pleased to expand our robust dry eye portfolio with REFRESH OPTIVE MEGA-3," said Herm Cukier, Senior Vice President, Eye Care. "Our REFRESH line of patented products offer patients a wide variety of options to treat their individual dry eye needs."
All OPTIVE products include the patented osmoprotectant formula that includes three compatible solutes -- glycerin, I-carnitine and erythritol -- all of which deliver added protection to the corneal epithelial cells against hypertonic stress. REFRESH OPTIVE MEGA-3 contains a fourth osmoprotectant, trehalose, for an advanced approach to treating Dry Eye symptoms.
MEGA-3 is available in 30-count single-use vials and can be found nationwide at various retail locations where OTC eye drops are sold.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance